Delirium is a serious medical condition that causes sudden confusion, difficulty thinking clearly, and changes in awareness.
People with delirium may become disoriented, have trouble paying attention, or not recognize where they are. It often develops quickly during illness, after surgery, or during a hospital stay, especially in older adults and people with long-term health problems.
Researchers from Stanford University and several other institutions have discovered that a widely used diabetes medicine may help lower the risk of delirium. Their findings, published in the journal Aging, suggest that metformin could also improve survival in people with type 2 diabetes.
Metformin has been used for decades to help people with type 2 diabetes control their blood sugar levels. It works by reducing the amount of sugar produced by the liver and helping the body respond better to insulin. Because it has a long record of safety and is inexpensive, it is one of the most commonly prescribed diabetes medicines worldwide.
In recent years, scientists have begun to notice that metformin may do more than lower blood sugar. Earlier studies have suggested that it may slow some age-related changes, reduce the risk of dementia, and improve overall health in older adults. These findings encouraged researchers to investigate whether the drug could also protect the brain from delirium.
For the new study, the research team analyzed information from 1,404 patients. They compared people with type 2 diabetes who regularly took metformin with those who had diabetes but did not use the medicine. The researchers then examined how often delirium occurred and how many patients survived over time.
The results were encouraging. Patients who took metformin were less likely to develop delirium than those who did not take the drug. They also had a lower risk of death during the study period, suggesting that metformin may provide benefits beyond diabetes control.
The researchers do not yet know exactly why metformin appears to protect the brain. It may reduce harmful inflammation, improve the way cells produce energy, or protect brain cells from damage. More studies are needed to confirm these findings and understand the biological processes involved.
Although these results are promising, they do not mean everyone should begin taking metformin. The study found a link between metformin use and better outcomes, but it does not prove that the medicine directly prevented delirium. Clinical trials will be needed before doctors can recommend metformin for this purpose.
For people living with type 2 diabetes, the best approach is still to work closely with a healthcare provider. Taking prescribed medication, eating a balanced diet, staying physically active, maintaining a healthy weight, getting enough sleep, avoiding smoking, and managing stress all play important roles in controlling blood sugar and reducing the risk of complications.
This study adds to growing evidence that some well-known medicines may have unexpected health benefits. If future research confirms these findings, metformin could become an important tool not only for managing diabetes but also for protecting brain health and improving long-term survival.
For now, the research offers encouraging news while reminding patients to discuss any treatment changes with their doctor.
If you care about diabetes, please read studies about 5 vitamins that may prevent complication in diabetes, and how to manage high blood pressure and diabetes with healthy foods.
For more health information, please see recent studies about vitamin D and type2 diabetes, and to people with type 2 diabetes, some fruits are better than others.
Copyright © 2026 Knowridge Science Report. All rights reserved.
